Cargando…

A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection

Japanese encephalitis virus (JEV) is the leading cause of epidemic encephalitis in Asia, and vaccination is the most effective way to prevent JE. Although several licensed vaccines were widely used, there is still a demand for developing safer, cheaper, and more effective JE vaccines. In the current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Limin, Xiao, Aibo, Wang, Hu, Zhang, Xiaojuan, Zhang, Yuan, Li, Yunlong, Wei, Yanqiu, Liu, Wenjun, Chen, Chuangfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877874/ https://www.ncbi.nlm.nih.gov/pubmed/35214656 http://dx.doi.org/10.3390/vaccines10020197

Ejemplares similares

Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
por: Garg, Himanshu, et al.
Publicado: (2020)

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus
por: Cao, Lei, et al.
Publicado: (2016)

Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice
por: Li, Jieqiong, et al.
Publicado: (2016)

A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice
por: Li, Na, et al.
Publicado: (2020)

A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection
por: Akahata, Wataru, et al.
Publicado: (2010)

IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability
por: Zhang, Yuan, et al.
Publicado: (2021)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2018)

The transmembrane replacement H7N9-VLP vaccine displays high levels of protection in mice
por: Qin, Jianru, et al.
Publicado: (2022)

Japanese encephalitis: The virus and vaccines
por: Yun, Sang-Im, et al.
Publicado: (2014)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

A rapid and quantitative fluorescent microsphere immunochromatographic strip test for detection of antibodies to porcine reproductive and respiratory syndrome virus
por: Wei, Yanqiu, et al.
Publicado: (2020)

Second Generation Inactivated Eastern Equine Encephalitis Virus Vaccine Candidates Protect Mice against a Lethal Aerosol Challenge
por: Honnold, Shelley P., et al.
Publicado: (2014)

A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice
por: Jones, R. Mark, et al.
Publicado: (2013)

Zika virus-like particle (VLP) based vaccine
por: Boigard, Hélène, et al.
Publicado: (2017)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)
por: Dye, John M., et al.
Publicado: (2016)

A DNA inducing VLP vaccine designed for HIV and tested in mice
por: Calazans, Alexandre, et al.
Publicado: (2017)

RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates
por: Huber, Bettina, et al.
Publicado: (2021)

Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
por: Erra, Elina O., et al.
Publicado: (2013)

Japanese Encephalitis Vaccines
por: Satchidanandam, Vijaya
Publicado: (2020)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice
Publicado: (2018)

Plant-produced transmission blocking Plasmodium falciparum Pfs25 subunit and VLP based vaccine candidates
por: Musivchuk, Konstantin, et al.
Publicado: (2012)

Partial cross-protection between Japanese encephalitis virus genotype I and III in mice
por: Wei, Jianchao, et al.
Publicado: (2019)

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
por: Spohn, Gunther, et al.
Publicado: (2010)

Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea
por: Kwak, Byung Ok, et al.
Publicado: (2021)

Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice
por: Zhao, Zhimin, et al.
Publicado: (2021)

A highly pathogenic porcine reproductive and respiratory syndrome virus candidate vaccine based on Japanese encephalitis virus replicon system
por: Hu, Pingsheng, et al.
Publicado: (2017)

Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model
por: Reguraman, Narendran, et al.
Publicado: (2023)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017)

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)

VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
por: Prates-Syed, Wasim A., et al.
Publicado: (2021)

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
por: Jelínková, Lucie, et al.
Publicado: (2023)

Safety of Japanese encephalitis vaccines
por: Hu, Ya-Li, et al.
Publicado: (2021)

Large-scale production and purification of VLP-based vaccines
por: Vicente, Tiago, et al.
Publicado: (2011)

RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
por: Wong, Ting Y., et al.
Publicado: (2022)

Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization
por: Hennrich, Alexandru A., et al.
Publicado: (2021)

Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
por: Braz Gomes, Kimberly, et al.
Publicado: (2021)

Analysis of fluoro based pyrazole analogues as a potential therapeutics candidate against Japanese encephalitis virus infection
por: Gupta, Anjali, et al.
Publicado: (2022)

Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature
por: Peabody, Julianne, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e2l0440j39alu2s1lshj7327ef